245 related articles for article (PubMed ID: 28002346)
21. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection.
Yang YT; Jiang JH; Yang HJ; Wu ZJ; Xiao ZM; Xiang BD
Sci Rep; 2018 Feb; 8(1):2535. PubMed ID: 29416061
[TBL] [Abstract][Full Text] [Related]
22. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection.
Ke MY; Zhang M; Su Q; Wei S; Zhang J; Wang Y; Wu R; Lv Y
J Surg Res; 2018 Nov; 231():403-410. PubMed ID: 30278960
[TBL] [Abstract][Full Text] [Related]
23. Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.
Wang WL; Zheng XL; Zhang ZY; Zhou Y; Hao J; Tang G; Li O; Xiang JX; Wu Z; Wang B
Medicine (Baltimore); 2016 Jul; 95(27):e4087. PubMed ID: 27399101
[TBL] [Abstract][Full Text] [Related]
24. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
[TBL] [Abstract][Full Text] [Related]
25. Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study.
Wang K; Guo W; Li N; Shi J; Zhang C; Lau WY; Wu M; Cheng S
Br J Cancer; 2014 Apr; 110(7):1811-9. PubMed ID: 24569461
[TBL] [Abstract][Full Text] [Related]
26. Decreased platelet distribution width predicts a worse prognosis in patients undergoing surgical resection for hepatocellular carcinoma.
Yue CX; Liu YX; Yun ZY; Li N; Zhao CJ; Wang RT
Cancer Biomark; 2019; 26(3):361-366. PubMed ID: 31594211
[TBL] [Abstract][Full Text] [Related]
27. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
[TBL] [Abstract][Full Text] [Related]
28. Preoperative serum ferritin is an independent prognostic factor for liver cancer after hepatectomy.
Wu SJ; Zhang ZZ; Cheng NS; Xiong XZ; Yang L
Surg Oncol; 2019 Jun; 29():159-167. PubMed ID: 31196483
[TBL] [Abstract][Full Text] [Related]
29. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
[TBL] [Abstract][Full Text] [Related]
30. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
[TBL] [Abstract][Full Text] [Related]
31. Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resection.
Yang HJ; Jiang JH; Yang YT; Guo Z; Li JJ; Liu XH; Lu F; Zeng FH; Ye JS; Zhang KL; Chen NZ; Xiang BD; Li LQ
Tumour Biol; 2017 Mar; 39(3):1010428317695944. PubMed ID: 28351330
[TBL] [Abstract][Full Text] [Related]
32. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
33. Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma.
Peng W; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
Medicine (Baltimore); 2016 Jul; 95(30):e4160. PubMed ID: 27472685
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma.
Kong W; Yang M; Zhang J; Cheng Y; Dai T; Zhang J; Wang G; Zhang J
BMC Cancer; 2021 Apr; 21(1):469. PubMed ID: 33906632
[TBL] [Abstract][Full Text] [Related]
35. Elevated platelet distribution width predicts poor prognosis in hepatocellular carcinoma.
Zuo X; Kong W; Feng L; Zhang H; Meng X; Chen W
Cancer Biomark; 2019; 24(3):307-313. PubMed ID: 30829614
[TBL] [Abstract][Full Text] [Related]
36. Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.
Xu XS; Wan Y; Song SD; Chen W; Miao RC; Zhou YY; Zhang LQ; Qu K; Liu SN; Zhang YL; Dong YF; Liu C
World J Gastroenterol; 2014 Aug; 20(31):10944-52. PubMed ID: 25152598
[TBL] [Abstract][Full Text] [Related]
37. Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis.
Lewis RH; Glazer ES; Bittenbinder DM; O'Brien T; Deneve JL; Shibata D; Behrman SW; Vanatta JM; Satapathy SK; Dickson PV
J Gastrointest Cancer; 2019 Dec; 50(4):808-815. PubMed ID: 30117090
[TBL] [Abstract][Full Text] [Related]
38. A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma.
Zhu Y; Xu D; Zhang Z; Dong J; Zhou Y; Zhang WW; Hong L; Zhu WW
Int J Surg; 2018 Sep; 57():45-53. PubMed ID: 30075291
[TBL] [Abstract][Full Text] [Related]
39. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma.
Xu Q; Yan Y; Gu S; Mao K; Zhang J; Huang P; Zhou Z; Chen Z; Zheng S; Liang J; Lin Z; Wang J; Yan J; Xiao Z
J Immunol Res; 2018; 2018():4925498. PubMed ID: 30027102
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.
Chan AW; Chan SL; Wong GL; Wong VW; Chong CC; Lai PB; Chan HL; To KF
Ann Surg Oncol; 2015 Dec; 22(13):4138-48. PubMed ID: 25801356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
